Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-10-18

FDA Approved: ORGOVYX — Supplemental Application (Sumitomo Pharma America, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for ORGOVYX (relugolix) submitted by Sumitomo Pharma America, Inc., resulting in changes to the product labeling. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ORGOVYX (RELUGOLIX)

Snippet

SUPPL AP for ORGOVYX (RELUGOLIX)